Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension in Patients With Suspicion of Pulmonary Hypertension

NCT03388476 is registered in ClinicalTrials.gov with University of Giessen as lead sponsor.

NCT NCT03388476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03388476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension in Patients With Suspicion of Pulmonary Hypertension
Lead sponsor
University of Giessen
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 2, 2018
Completion date
January 1, 2035
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic thromboembolic pulmonary hypertension, hypertension, pulmonary, hypertension;pulmonary;primary, lung diseases, vascular diseases